The newly finished facility has added 125 jobs in recent months, with a full 300 coming on stream in just two years of expansion.
The last stage was brought about by the Valeant Pharmaceuticals-owned company’s need to meet the consumer demand of its contact lens portfolio.
The investment further strengthens the Waterford plant’s position in supporting the company’s global efforts in increasing market share in the daily disposable contact lens market.
One product, in particular, called Biotrue ONEday, was developed in Waterford, …read more
Source:: Silicon Republic News